Open research questions in Gastric Cancer Management and Outcomes
665 gap statements mined from Gastric Cancer Management and Outcomes papers in our 7.9M-paper local library, which holds 2,865 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Gastric Cancer Management and Outcomes? See the ranked Medicine journals.
What the literature leaves open
The current evidence on the impact of previous abdominal surgery on perioperative outcomes after minimally invasive gastrectomy for gastric cancer is inconsistent. There is a need for a quantitative analysis of comparative studies to evaluate the effect of previous abdominal surgery on perioperative outcomes.
Impact of previous abdominal surgery on perioperative outcomes after minimally invasive gastrectomy for gastric cancer: an evidence synthesis and quantitative analysis · 2026 · DOIThe next phase of metastasis research should combine paired primary and metastatic lesions, serial liquid biopsies, singlecell and spatial multi-omics, and phylogenetic reconstruction. Research on lymph-node-specific prediction and intervention is needed.
Metastasis Pattern‐Specific Biomarkers and Therapeutic Targets in Gastric Cancer: From Surgical Specimens to Clinical Translation · 2026 · DOIThe study highlights the need for larger independent cohorts to validate the findings.
Exploring Molecular Determinants of Long-Term Survival in Metastatic Gastric Cancer: An mRNA Expression Pilot Study · 2026 · DOIData on the epidemiology and trends of gastric cancer in Bangladesh remain limited. There is a need to analyze the demographic characteristics, endoscopic findings, and histopathological reports of gastric cancer patients in Bangladesh.
Assessing the Epidemiological Trend of Gastric Cancer: A Retrospective Analysis From a Tertiary Care Hospital in Bangladesh · 2026 · DOIThe lack of a comprehensive review of the clinical and biological continuum of gastric cancer, from epidemiology to management, with a focus on macrophages poses a challenge for understanding the disease.
Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management · 2026 · DOINeed for a model that incorporates multiple variables, including oncologic characteristics and treatment strategy. Limited generalizability of prior studies due to lack of external validation.
Treatment Effects of Different Therapeutic Strategies and Development of a Prognostic Prediction Model for Early Gastric Cancer: A Population-Based and Multicenter Study · 2026 · DOIThe reliability and consistency of EUS in the locoregional staging of gastric cancer have been increasingly called into question. There is a need for emerging techniques to improve the accuracy of EUS. The paper identifies a gap in the current literature regarding the applications of EUS in gastric cancer.
Endoscopic Ultrasound (EUS) in Gastric Cancer: Current Applications and Future Perspectives · 2025 · DOIBecause comparative data of both methods are lacking, we aimed to compare the clinical outcomes between EFTR and LECS for gastric SMT.
Clinical Outcomes of Endoscopic Full‐Thickness Resection Versus Laparoscopic and Endoscopic Cooperative Surgery: A Propensity Score‐Matched Comparative Study · 2026 · DOIAlthough Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) is used for risk stratification, it remains poorly defined whether gastric intestinal metaplasia (IM) follows reproducible anatomic patterns or has structured evolution.
Reproducible Topographic Phenotypes and Three‐Phase Anatomical Evolution of Gastric Intestinal Metaplasia · 2026 · DOIRandomized evidence is insufficient to establish a consistent DFS or OS benefit from routine postoperative CRT over effective CT after R0 D2 gastrectomy.
Adjuvant chemoradiotherapy vs chemotherapy after R0 D2 gastrectomy for gastric cancer: Meta-analysis of randomized trials · 2026 · DOISevere toxicity and treatment completion were not pooled because reporting was insufficiently comparable.
Adjuvant chemoradiotherapy vs chemotherapy after R0 D2 gastrectomy for gastric cancer: Meta-analysis of randomized trials · 2026 · DOIGastric cancer is a major global health burden, but histologic subtype-specific epidemiologic and survival trends remain unclear.
Trends in Gastric Cancer Incidence, Mortality, and Survival by Histologic Subtype in the United States (2000–2022) and a Contemporary Chinese Cohort · 2026 · DOISince results of the Trastuzumab for Gastric Cancer (ToGA) trial were published in 2010, the addition of trastuzumab to chemotherapy is the standard of care for first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive metastatic gastroesophageal adenocarcinoma, yet data from European real-world cohorts are scarce.
Trastuzumab in Addition to Chemotherapy in Patients With Metastatic Human Epidermal Growth Factor Receptor 2–Positive Gastroesophageal Cancer—A Real-World Experience · 2026 · DOIThe learning process for probe-based confocal laser endomicroscopy (pCLE) is challenging, and standardized training protocols are currently lacking.
Establishment and Evaluation of a Probe-Based Confocal Laser Endomicroscopy Training System for Gastric Cancerous Lesions Diagnosis: Evidence From a National Training Program · 2026 · DOITo date, clinicians' views on this technology for precision oncology have not been reported despite these insights being invaluable to understanding how organoids may be effectively integrated into clinical practice.
The role of gastric cancer patient-derived organoids in precision medicine: Clinicians’ perspective · 2026 · DOIThe optimal management strategy in patients undergoing curative-intent treatment remains unclear.
Curative-intent treatment for distal gastric cancer with gastric outlet obstruction: Management pathways and clinical outcomes from a Swedish multicenter cohort · 2026 · DOIGastric cancer exhibits diverse patterns of lymph node (LN) metastasis, yet the relationship between LN stations and tumor location, histological subtype and pT-stage remains unclear.
Nodal metastatic pattern in gastric cancer: A descriptive study of a single institution cohort · 2026 · DOIObjectiveRobotic-assisted distal gastrectomy (RADG) and laparoscopic distal gastrectomy (LDG) serve as minimally invasive alternatives to open distal gastrectomy (ODG); however, the magnitude of their perioperative benefits remains controversial.
Single-center, retrospective cohort study of perioperative outcomes in robotic-assisted, laparoscopic, and open distal gastrectomy: A propensity score matching analysis · 2026 · DOIAlthough precursor gastric lesions are commonly identified, adherence to current recommendations for their surveillance and to established quality indicators in EGDs is scarce.
Tackling Post‐Endoscopy Gastric Cancer in a Low‐Risk Area: Prevalence, Features, and Prevention Opportunities Through Better Clinical Practice · 2025 · DOILimited number of studies - Insufficient subgroup-specific data - Observational studies with low certainty of evidence - Limited generalizability due to heterogeneity across…
Impact of previous abdominal surgery on perioperative outcomes after minimally invasive gastrectomy for gastric cancer: an evidence synthesis and quantitative analysis · 2026 · DOIThe study was conducted in an exploratory, hypothesis-generating framework, - The sample size was limited, - The analyses were regarded as exploratory and were interpreted conservatively, - No prognostic or causal interpretation was assigned to cluster…
Exploring Molecular Determinants of Long-Term Survival in Metastatic Gastric Cancer: An mRNA Expression Pilot Study · 2026 · DOIInvestigating the role of macrophages in GC, - Exploring therapeutic strategies targeting macrophages, - Studying the relationship between GC…
Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management · 2026 · DOILimited availability of molecular techniques in many institutions - High cost of molecular techniques - Absence of optimal markers for diagnosing each molecular type - Complexity of molecular…
Molecular Classifications in Gastric Cancer: A Call for Interdisciplinary Collaboration · 2024 · DOIDevelopment of consensus molecular categories - Design of innovative molecular studies - Validation of molecular classifications - Search for alternative molecular…
Molecular Classifications in Gastric Cancer: A Call for Interdisciplinary Collaboration · 2024 · DOINotably, two patients in our cohort exhibited congenital tooth agenesis, a phenotypical feature rarely reported in patients with HDGC and previously undocumented in East Asian cohorts.
Dental agenesis as a novel phenotypical feature associated with hereditary diffuse gastric cancer in China · 2025 · DOI
Most-cited papers in Gastric Cancer Management and Outcomes
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial · The Lancet · 2010 · 6,142 citations
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer · New England Journal of Medicine · 2006 · 5,299 citations
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction · New England Journal of Medicine · 2001 · 2,708 citations
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial · The Lancet · 2021 · 2,649 citations
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial · The Lancet · 2019 · 2,366 citations
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine · New England Journal of Medicine · 2007 · 2,095 citations
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial · The Lancet · 2017 · 1,962 citations
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial · The Lancet · 2013 · 1,821 citations
- Japanese gastric cancer treatment guidelines 2018 (5th edition) · Gastric Cancer · 2020 · 1,534 citations
- Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology · Journal of the National Comprehensive Cancer Network · 2022 · 1,519 citations
Most recent work
- Japanese gastric cancer treatment guidelines 2025 (7th edition) · Gastric Cancer · 2026
- Multimodal digital biopsy for preoperative prediction of occult peritoneal metastasis in gastric cancer · npj Digital Medicine · 2026
- Intratumoral heterogeneity and chemotherapy-induced alteration of CLDN18.2 expression in resectable gastric cancer · International Journal of Clinical Oncology · 2026
- A multimodal deep learning model for preoperative prediction of post-operative complications in gastric cancer · Annals of Oncology · 2026
- Oncological impact of universal endoscopic submucosal dissection for large Barrett’s cancers · Gut · 2026
- Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort · ESMO Open · 2026
- Textbook outcome in gastric cancer surgery: a multicenter cohort study and proposal for a new specific index (TOGS) · Gastric Cancer · 2026
- Changing landscape in stage, treatment and survival of gastric cancer in China 1998–2022: Insights of 40,158 patients from the National Gastric Cancer Cohort · Cancer Letters · 2026
- Targeting claudin 18.2 in gastric cancer: a review of emerging biologic agents · Expert Opinion on Biological Therapy · 2026
- The use of diluted epinephrine during gastric endoscopic submucosal dissection: an international randomized controlled trial · Gastrointestinal Endoscopy · 2026
Find a gap in your own Gastric Cancer Management and Outcomes sub-topic
This page shows what the Gastric Cancer Management and Outcomes literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →